A phase I/II trial of gefitinib and radiotherapy in patients with locally advanced inoperable squamous cell carcinoma of the head and neck-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A phase I/II trial of gefitinib and radiotherapy in patients with locally advanced inoperable squamous cell carcinoma of the head and neck

Published:2008-08 Issue:7 Volume:19 Page:739-744
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Caponigro Francesco,Romano Carmen,Milano Amalia,Solla Raffaele,Franchin Giovanni,Adamo Vincenzo,Mari Ettore,Morrica Brunello,Pepe Stefano

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference17 articles.

1. Targeting EGF-receptor-signalling in squamous cell carcinomas of the head and neck;Reuter;Br J Cancer,2007

2. Characterization, quantification, and potential clinical value of the epidermal growth factor receptor in head and neck squamous cell carcinomas;Santini;Head Neck,1991

3. Critical update and emerging trends in epidermal growth factor receptor targeting in cancer;Baselga;J Clin Oncol,2005

4. Critical role of both p27KIP1 and p21CIP1/WAF1 in the antiproliferative effect of ZD1839 (‘Iressa’), an epidermal growth factor receptor tyrosine kinase inhibitor, in head and neck squamous carcinoma cells;Di Gennaro;J Cell Physiol,2003

5. Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck;Cohen;J Clin Oncol,2003

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting the ErbB Family in Head and Neck Cancer;Molecular Determinants of Head and Neck Cancer;2018

2. Current Role of Dacomitinib in Head and Neck Cancer;Expert Opinion on Investigational Drugs;2016-05-03

3. Balancing Safety and Efficacy of Epidermal Growth Factor Receptor Inhibitors in Patients With Squamous Cell Carcinoma of the Head and Neck;The Oncologist;2015-10-07

4. Molecular Biology and Immunology of Head and Neck Cancer;Surgical Oncology Clinics of North America;2015-07

5. Early investigational drugs that target epidermal growth factor receptors for the treatment of head and neck cancer;Expert Opinion on Investigational Drugs;2014-08-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3